Loading patent…
AssigneeZambon S.p.A.
InventorsAntonio Esteras, Leonida Bruseguini, Jose Maria Estrela
Estimating the term…
A method for prevention of cell death, and method comprising simultaneously topically applying N-acetylcysteine and levulose as an application in an amount effective to result in a synergistic action protecting cells, and preventing cell damage caused by various agents. A method of preparing pharmaceutical compounds that protect cells against damage induced by a member selected from the group consisting of hypoxia/anoxia, oxidative stress, xenobiotic agents, ionizing radiations, and conditions causing toxic stress, which involves forming a combination comprising N-acetylcysteine and levulose. A pharmaceutical preparation including a combination of N-acetylcysteine and levulose.
A method for prevention of cell death, said method comprising simultaneously administering N-acetylcysteine and levulose as an application in an amount effective to result in protecting cells, and preventing cell damage caused by various agents.
A method of preparing pharmaceutical compounds that protect cells against damage induced by a member selected from the group consisting of hypoxia/anoxia, oxidative stress, xenobiotic agents, ionizing radiations, and conditions causing toxic stress, said method comprising forming a combination comprising N-acetylcysteine and levulose wherein said N-acetylcysteine and said levulose are present in a proportion comprising a molar ratio of 1/1 to 5/1.
A method of forming a pharmaceutical preparation, said method comprising:
A pharmaceutical preparation comprising a combination of N-acetylcysteine and levulose, wherein said N-acetylcysteine and said levulose are present in a proportion comprising a molar ratio of 1/1 to 5/1.
Dependencies are inferred from the claim text.